[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Understanding the PROMISE and PCROWD Studies with Dana Farber

Understanding the PROMISE and PCROWD Studies with Dana Farber image

Understanding the PROMISE and PCROWD Studies with Dana Farber

Webinar
event Jun 09, 2022 / 06:30PM - 08:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

This month we are focusing on the PROMISE and PCROWD studies that are being conducted Dana Farber staff. These are studies meant to further myeloma research. The PROMISE study is to identify new ways to prevent multiple myeloma in individuals with its precursor conditions. The PCROWD study is a medical research data bank. They study blood samples and analyze data about early phases of blood conditions that may develop into cancer. This is a great opportunity for you and your loved ones to contribute to important myeloma research.

Schedule & Agenda

Event panelist Audrey Burton-Bethkee
06:30 PM
Introduction
Audrey Burton-Bethkee
Audrey introduces the agenda of the event and featured speakers Erica, Maya and Majorie from Dana Farber.
Event panelist Marjorie Marto
06:35 PM
Myeloma and Precursor Conditions
Marjorie Marto
Event panelist Maya Inez Davis
06:45 PM
PROMISE Study
Maya Inez Davis
Event panelist Erica Horowitz
06:55 PM
PCROWD
Erica Horowitz
Event panelist Staff
07:05 PM
CPOP
Staff
Event panelist Audience
07:15 PM
Questions and Answers
Audience

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Maya Inez Davis
Maya Inez Davis

As a clinical research coordinator on the PROMISE Study, her primary responsibilities are to oversee the Positive Cohort and lead our Black Community Engagement effort. Her career goal is to work as a physician decreasing the current gaps in our healthcare system that disproportionally affect minority populations. She joined the PROMISE Study in August of 2020 primarily because of the work the study is doing to decrease barriers to accessing care, but also because people of African descent have 2-3 times the risk for Multiple Myeloma and its precursor conditions. She is grateful for the opportunity to improve the patient care experience and connect with their wonderful study participants.

Read Bio
The panelist Erica M. Horowitz
Erica M. Horowitz

As a Clinical Research Coordinator with the PCROWD and IMPACT studies, her main responsibilities are to manage the day-to-day operations, patient communication, and assist in data management with their lab techs and PHD fellows. Her career goal is to become a physician. She joined the Ghobrial Lab in August of 2020 because of the work the Lab is doing to increase awareness surrounding Multiple Myeloma and the importance of screening. Her family, like so many others, have dealt with the repercussions when diagnoses are discovered too late and our Lab and the studies she works with are trying to screen and treat patients before they become symptomatic. She is so thankful to be a part of this team and work with their study participants!

Read Bio
The panelist Marjorie Marto, PA-C
Marjorie Marto, PA-C

Marjorie Marto is a Physician Assistant at Dana Farber Cancer Institute’s Center for Prevention of Progression. She graduated from the Yale School of Medicine Physician Associate Program and soon thereafter, launched a career in oncology. Beginning in bone marrow transplant, Marjorie moved to a community oncology practice for many years before returning to focus again on hematologic malignancies and disorders. She joined Dana Farber’s precursor clinic in Jan 2022 because of the exciting research opportunities to learn how we can intercept these conditions before they progress to malignancy and ultimately, make impactful changes to the current standard of patient care.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Northeast Regional Cure Team group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.